Back
CRISPR Therapeutics AG Vs. Editas Medicine Industry Stock Comparison
Sell
30
CRSP
CRISPR Therapeutics AG
Last Price:
44.58
Seasonality Move:
6.48%
Sell
29
EDIT
Editas Medicine
Last Price:
3.60
Seasonality Move:
-2.38%
Sell
30
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
- The current CRISPR Therapeutics AG [CRSP] share price is $44.62. The Score for CRSP is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CRSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy, Sell or Hold?
- The current Editas Medicine [EDIT] share price is $3.60. The Score for EDIT is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- EDIT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $44.62
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing slight buying pressure.
EDIT Stock Price Chart
What is Editas Medicine's stock price today?
-
The Editas Medicine share price today is $3.60
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.9 | Sell |
Relative Strength Index (14 RSI): | 35.02 | Sell |
Chaikin Money Flow: | 106871 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.24 - 49.44) | Sell |
Bollinger Bands (100): | (49.81 - 58.91) | Sell |
EDIT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.31 | Sell |
Relative Strength Index (14 RSI): | 36.25 | Sell |
Chaikin Money Flow: | 1542488 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.59 - 4.33) | Sell |
Bollinger Bands (100): | (4.31 - 5.71) | Sell |
CRSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.43 | Sell |
20-day SMA: | 47.55 | Sell |
50-day SMA: | 52.01 | Sell |
200-day SMA: | 61.76 | Sell |
8-day EMA: | 46.16 | Sell |
20-day EMA: | 47.9 | Sell |
50-day EMA: | 51.21 | Sell |
200-day EMA: | 57.09 | Sell |
EDIT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.63 | Sell |
20-day SMA: | 3.82 | Sell |
50-day SMA: | 4.58 | Sell |
200-day SMA: | 6.89 | Sell |
8-day EMA: | 3.64 | Sell |
20-day EMA: | 3.9 | Sell |
50-day EMA: | 4.45 | Sell |
200-day EMA: | 6.25 | Sell |
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.54 per share, an increase next quarter of $0.00 per share, a decrease this year of $2.74 per share, and an increase next year of $0.45 per share.
Editas Medicine Earnings Growth & EDIT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.10 per share, a decrease this year of $0.68 per share, and an increase next year of $0.17 per share.
CRISPR Therapeutics AG Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Editas Medicine Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |